SCHEDULE: Amwell Founders Disclose 51% Voting Control

Ido and Roy Schoenberg, co-founders of American Well Corp, have jointly disclosed beneficial ownership representing 51% of the company's total voting power through a voting agreement.

Summary

• Ido Schoenberg and Roy Schoenberg, co-founders of American Well Corp, have filed an Amendment No. 5 to Schedule 13G, disclosing their beneficial ownership of the company's Class A Common Stock.
• Ido Schoenberg beneficially owns 831,642 shares, representing 5.4% of the class, comprising Class A shares, Class B shares, and Class B options.
• Roy Schoenberg beneficially owns 892,499 shares, representing 5.7% of the class, comprising Class A shares, Class B shares, and Class B options.
• The Schoenberg brothers are parties to a voting agreement, agreeing to vote their shares together as a group.
• Due to this agreement, they collectively hold 51% of the aggregate voting power of American Well Corp's issued and outstanding share capital.
• Each Class B Common Stock share is convertible into one Class A Common Stock share at the holder's option.
• Class B Common Stock collectively holds 51% of the total outstanding voting power, achieved through a specific voting multiplier.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this filing as neutral to slightly positive. While the concentrated voting power could be a governance concern for some, it also signals stability and continued founder commitment, which can be reassuring for long-term investors in a growth-oriented company like Amwell.

Positives

• Founders Ido and Roy Schoenberg maintain significant beneficial ownership, demonstrating continued vested interest in the company's performance.
• Their collective 51% voting power provides stable leadership and strategic direction, potentially reducing the risk of hostile takeovers or disruptive activist investor campaigns.

Negatives

• The concentration of 51% voting power in the hands of two individuals, even founders, could limit the influence of other shareholders on corporate decisions.
• The dual-class share structure, where Class B shares carry disproportionate voting rights, can be viewed negatively by some governance advocates as it separates economic interest from voting control for Class A shareholders.

Risks

• Concentrated voting power (51%) with Ido and Roy Schoenberg means that a significant portion of corporate decisions can be controlled by them, potentially overriding the interests of minority shareholders.
• The dual-class share structure, where Class B shares have enhanced voting rights, could lead to governance concerns regarding accountability to public shareholders.

Future Outlook

NA

Management Comments

• "In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to (i) this joint filing on behalf of each of them of a statement on Schedule 13G (including any amendments thereto) with respect to the Class A Common Stock of American Well Corporation, par value $0.01 per share, and (ii) that this Joint Filing Agreement be included as an exhibit to such joint filing..."

Industry Context

StockSavvy.ai notes that in the telehealth and healthcare technology sector, founder-led companies often employ dual-class share structures to maintain strategic control and long-term vision amidst rapid industry evolution and competitive pressures. This structure allows founders to pursue long-term growth strategies without undue pressure from short-term market fluctuations or activist investors, which is a common theme in high-growth tech sectors.

Comparison to Industry Standards

• The dual-class share structure with founders retaining 51% voting control is common among technology and growth companies, such as Meta Platforms (Facebook), Alphabet (Google), and Snap Inc., where founders sought to protect their long-term vision from short-term market pressures.
• While providing stability, this structure deviates from the "one share, one vote" principle favored by many institutional investors and governance bodies, which is the standard for mature, widely held companies like Johnson & Johnson or Pfizer in the broader healthcare industry.
• The Schoenberg brothers' combined 51% voting power is a significant concentration, comparable to the control held by founders in companies like Ford Motor Company (Ford family) or The New York Times Company (Sulzberger family), though these are often multi-generational arrangements.

Corporate Governance

Related Party Transactions

• The joint filing agreement and the voting agreement between Ido Schoenberg and Roy Schoenberg, who are brothers and co-founders, constitute a related party arrangement impacting corporate control.

Stakeholder Impact

• Shareholders: Class A shareholders may have reduced influence on corporate decisions due to the concentrated voting power of the founders through the dual-class structure and voting agreement.
• Management: The founders' strong voting control provides stability for the current management team and strategic direction.
• Creditors: No direct impact on creditors is indicated by this ownership disclosure.

Key Dates

Recommendation

This filing is a routine disclosure of beneficial ownership and does not present new information that would fundamentally alter the investment thesis for American Well Corp. The concentrated founder control is a known aspect of the company's governance structure. Investors should continue to evaluate the company based on its operational performance, financial results, and strategic execution within the competitive telehealth market.

Keywords

American Well Corp, Amwell, AWL, Ido Schoenberg, Roy Schoenberg, Schedule 13G, beneficial ownership, voting power, Class A Common Stock, Class B Common Stock, corporate governance, founder ownership, SEC filing, telehealth, healthcare technology